1
|
Markus B, C GC, Andreas K, Arkadij K, Stefan L, Gustav O, Elina S, Radka S. Accelerating Biocatalysis Discovery with Machine Learning: A Paradigm Shift in Enzyme Engineering, Discovery, and Design. ACS Catal 2023; 13:14454-14469. [PMID: 37942268 PMCID: PMC10629211 DOI: 10.1021/acscatal.3c03417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Revised: 09/29/2023] [Accepted: 10/03/2023] [Indexed: 11/10/2023]
Abstract
Emerging computational tools promise to revolutionize protein engineering for biocatalytic applications and accelerate the development timelines previously needed to optimize an enzyme to its more efficient variant. For over a decade, the benefits of predictive algorithms have helped scientists and engineers navigate the complexity of functional protein sequence space. More recently, spurred by dramatic advances in underlying computational tools, the promise of faster, cheaper, and more accurate enzyme identification, characterization, and engineering has catapulted terms such as artificial intelligence and machine learning to the must-have vocabulary in the field. This Perspective aims to showcase the current status of applications in pharmaceutical industry and also to discuss and celebrate the innovative approaches in protein science by highlighting their potential in selected recent developments and offering thoughts on future opportunities for biocatalysis. It also critically assesses the technology's limitations, unanswered questions, and unmet challenges.
Collapse
Affiliation(s)
- Braun Markus
- Department
of Biochemistry, Graz University of Technology, Petersgasse 12/2, 8010 Graz, Austria
| | - Gruber Christian C
- Enzyme
and Drug Discovery, Innophore. 1700 Montgomery Street, San Francisco, California 94111, United States
| | - Krassnigg Andreas
- Enzyme
and Drug Discovery, Innophore. 1700 Montgomery Street, San Francisco, California 94111, United States
| | - Kummer Arkadij
- Moderna,
Inc., 200 Technology
Square, Cambridge, Massachusetts 02139, United States
| | - Lutz Stefan
- Codexis
Inc., 200 Penobscot Drive, Redwood City, California 94063, United States
| | - Oberdorfer Gustav
- Department
of Biochemistry, Graz University of Technology, Petersgasse 12/2, 8010 Graz, Austria
| | - Siirola Elina
- Novartis
Institute for Biomedical Research, Global Discovery Chemistry, Basel CH-4108, Switzerland
| | - Snajdrova Radka
- Novartis
Institute for Biomedical Research, Global Discovery Chemistry, Basel CH-4108, Switzerland
| |
Collapse
|
2
|
Hao Z, Guo Q, Feng Y, Zhang Z, Li T, Tian Z, Zheng J, Da LT, Peng W. Investigation of the Catalytic Mechanism of a Soluble N-glycosyltransferase Allows Synthesis of N-glycans at Noncanonical Sequons. JACS Au 2023; 3:2144-2155. [PMID: 37654596 PMCID: PMC10466321 DOI: 10.1021/jacsau.3c00214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 07/21/2023] [Accepted: 07/24/2023] [Indexed: 09/02/2023]
Abstract
The soluble N-glycosyltransferase from Actinobacillus pleuropneumoniae (ApNGT) can establish an N-glycosidic bond at the asparagine residue in the Asn-Xaa-Ser/Thr consensus sequon and is one of the most promising tools for N-glycoprotein production. Here, by integrating computational and experimental strategies, we revealed the molecular mechanism of the substrate recognition and following catalysis of ApNGT. These findings allowed us to pinpoint a key structural motif (215DVYM218) in ApNGT responsible for the peptide substrate recognition. Moreover, Y222 and H371 of ApNGT were found to participate in activating the acceptor Asn. The constructed models were supported by further crystallographic studies and the functional roles of the identified residues were validated by measuring the glycosylation activity of various mutants against a library of synthetic peptides. Intriguingly, with particular mutants, site-selective N-glycosylation of canonical or noncanonical sequons within natural polypeptides from the SARS-CoV-2 spike protein could be achieved, which were used to investigate the biological roles of the N-glycosylation in membrane fusion during virus entry. Our study thus provides in-depth molecular mechanisms underlying the substrate recognition and catalysis for ApNGT, leading to the synthesis of previously unknown chemically defined N-glycoproteins for exploring the biological importance of the N-glycosylation at a specific site.
Collapse
Affiliation(s)
- Zhiqiang Hao
- Key
Laboratory of Systems Biomedicine (Ministry of Education), Shanghai
Center for Systems Biomedicine, Shanghai
Jiao Tong University, Shanghai 200240, China
| | - Qiang Guo
- Key
Laboratory of Systems Biomedicine (Ministry of Education), Shanghai
Center for Systems Biomedicine, Shanghai
Jiao Tong University, Shanghai 200240, China
| | - Yuanyuan Feng
- State
Key Laboratory of Microbial Metabolism, School of Life Sciences and
Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
| | - Zihan Zhang
- Shanghai
Key Laboratory of Chemical Assessment and Sustainability, School of
Chemical Science & Engineering, Tongji
University, Shanghai 200092, China
| | - Tiantian Li
- Key
Laboratory of Systems Biomedicine (Ministry of Education), Shanghai
Center for Systems Biomedicine, Shanghai
Jiao Tong University, Shanghai 200240, China
| | - Zhixin Tian
- Shanghai
Key Laboratory of Chemical Assessment and Sustainability, School of
Chemical Science & Engineering, Tongji
University, Shanghai 200092, China
| | - Jianting Zheng
- State
Key Laboratory of Microbial Metabolism, School of Life Sciences and
Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
| | - Lin-Tai Da
- Key
Laboratory of Systems Biomedicine (Ministry of Education), Shanghai
Center for Systems Biomedicine, Shanghai
Jiao Tong University, Shanghai 200240, China
| | - Wenjie Peng
- Key
Laboratory of Systems Biomedicine (Ministry of Education), Shanghai
Center for Systems Biomedicine, Shanghai
Jiao Tong University, Shanghai 200240, China
| |
Collapse
|